CS logo
small CS logo
Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology

Bad Nauheim, Germany

About Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology


During the past decade, Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology" #1 sponsor was "Gabriela Riemekasten" with 1 trials, followed by "Gabriele Valentini" with 1 trials sponsored, "Prof. Laszlo Czirjak" with 1 trials sponsored, "University of Paris 5 - Rene Descartes" with 1 trials sponsored and "marco matucci cerinic" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology" #1 collaborator was "Charite University, Berlin, Germany" with 5 trials as a collaborator, "European Union" with 5 trials as a collaborator, "Schoen Klinik Hamburg Eilbek" with 5 trials as a collaborator, "University College, London" with 5 trials as a collaborator and "University of Basel" with 5 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 12 trials.

Clinical Trials Conditions at Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology


According to Clinical.Site data, the most researched conditions in "Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology" are "Systemic Sclerosis" (5 trials), "Arthritis" (1 trials), "Cardiac Arrhythmia" (1 trials), "Cardiac Diseases" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology" in a lesser frequency.

Clinical Trials Intervention Types at Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology


Clinical Trials Genders at Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology


The vast majority of trials in "Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology" are 5 trials for "All" genders.

Clinical Trials Status at Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology


Currently, there are NaN active trials in "Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".